Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers
In light of the limited number of targetable oncogenic drivers in breast cancer (BRCA), it is important to identify effective and druggable gene targets for the treatment of this devastating disease. Herein, the GSE102484 dataset containing expression profiling data from 683 BRCA patients was re-ana...
Main Authors: | Daowu Yu, Shengwei Liu, Yijun Chen, Lumeng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.944259/full |
Similar Items
-
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
by: Yanjing Guo, et al.
Published: (2023-02-01) -
Bilateral Paget’s Disease of the Breast in a Patient with CHEK2 Mutation
by: Nicci Owusu-Brackett, et al.
Published: (2020-04-01) -
Nuclear expression of Ku70/80 is associated with CHEK2 germline mutations in breast cancer
by: Rosik Jakub, et al.
Published: (2023-07-01) -
Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis
by: Natalia Alonso, et al.
Published: (2024-02-01) -
Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer
by: Rachel Topno, et al.
Published: (2021-03-01)